Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients

PURPOSE: To investigate factors associated with good response to intravitreal bevacizumab (IVB) in central serous chorioretinopathy (CSC) patients. METHODS: We retrospectively reviewed 42 eyes of CSC patients of symptom duration more than 3 months who received a single or multiple successive IVBs on...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eye (Lond)
Egile Nagusiak: Kim, G A, Rim, T H, Lee, S C, Byeon, S H, Koh, H J, Kim, S S, Lee, C S
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2015
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4469674/
https://ncbi.nlm.nih.gov/pubmed/25952951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.58
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak